# A Study to Evaluate the Safety and Effectiveness of Kytogen Defend in Facial Skin Quality Improvement in Adult Participants

> **NCT07179198** · NA · NOT_YET_RECRUITING · sponsor: **Sinclair Pharmaceuticals Limited** · enrollment: 500 (estimated)

## Conditions studied

- Skin Quality

## Interventions

- **DEVICE:** KIO021

## Key facts

- **NCT ID:** NCT07179198
- **Lead sponsor:** Sinclair Pharmaceuticals Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-22
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07179198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07179198, "A Study to Evaluate the Safety and Effectiveness of Kytogen Defend in Facial Skin Quality Improvement in Adult Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07179198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*